Company profilePharmaceutical#8 of 1,318 in Pakistan✓ No DRAP alerts

VALOR PHARMACEUTICALS

Pharmaceutical company · 444 brands · 406 molecules

Ranked #1 of 31 companies in Antifungal For Dermatological

444 registered products 90 pharmaceutical brands 406 distinct molecules 0 DRAP alerts

Company overview

444
registered products
90
pharmaceutical brands
406
distinct molecules
12
therapeutic classes
0
DRAP alerts

VALOR PHARMACEUTICALS is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 444 product registrations across 406 distinct molecules. It is the 8th largest registrant in Pakistan by product count, and ranks 1st of 31 in Antifungal For Dermatological. Its portfolio is concentrated in Antifungal For Dermatological and Skin Conditions. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by VALOR

251 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

197
ceilings with an approval date
2
not revised in 2+ years
2024
oldest approval year
20242
2025195
Longest without revision

Top molecules by brand count

Betamethasone13 brands
Clotrimazole11 brands
Eye10 brands
Ciprofloxacin10 brands
Amlodipine9 brands
Clindamycin9 brands
Levofloxacin8 brands
Isotretinoin7 brands

Therapeutic classes

Antifungal For Dermatological · 9Skin Conditions · 8Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 8Anti-Acne Preparations · 8Anti-Infective, Ophthalmologicals · 6Antibiotics For Topical Use · 5Corticosteroid, Plain · 5Corticosteroid Combinations, Topical · 5Blood Glucose Lowering Drugs, Excluding Insulin · 4Quinolone Antibacterials · 4Antipsoriatics · 3Antithrombotic Agents · 3

Conditions treated

Acne/Topical · 3Hyperpigmentation · 2Parkinson'S Disease · 1Infection/Allergy · 1Migraine/Vertigo · 1Acne/Oral · 1Scabies · 1Fungal Infection · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official367 products · Rs 19 – Rs 14,349.41
DVAGO34 products · Rs 16.3 – Rs 2,142.25
Servaid13 products · Rs 57.29 – Rs 1,194
Median across source: Rs 247.65

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Atco Pharma International (Pvt) Ltd holds 160 molecules not in this portfolio
Acetylsalicylic AcidAlbuterolAminophyllineAmlodipine 6.95Mg Amlodipine BaseAmlodipine,Atorvastatin CalciumAmmonium Chloride
BIO LABS (PVT) LTD. holds 83 molecules not in this portfolio
AprepitantAremetherArtesunateAtorvastatinAzathioprineAzithromycin 250Mg
NEUTRO PHARMA (PVT) LTD. holds 82 molecules not in this portfolio
AmikacinAnastrazoleAnastrozoleAntimonyAripiprazoleAzathioprine

Get the full profile for VALOR

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.